AYTU Aytu BioPharma announced today that the FDA has granted Fast Track designation to AR101, a protein kinase inhibitor, for the treatment of patients with Vascular Ehlers-Danlos Syndrome.
After the bullish news, AYTU stock hit the all time low level.
52 Week Range 0.76 - 7.20
LADENBURG THALM has a price target of $14.50 for the stock.
I think a reversal is...
Note that the $1.30 price range is a key loading point to get the momentum required to break past the 1.80 price range , If we break past here the next point of resistance would be the 2.05 . Failing to break these levels we could see a 1.30 barcode or even a 1.20 for the comming weeks.
First off, don't take anything I say seriously or at face value, as always this is on opinion basis. That being said, let us get into the points I want to make. AYTU seems to be at one would say a sudden bullish run, as it looks like the resistance curve is about to burst. The earnings call is on May 07th, and alot of price correlations and fluctuations can change...
